University of Cologne | MedPath Search

Found 407 clinical trials|View Analysis

Sort by:

Need a comprehensive medical report on "University of Cologne"?

Analyze the latest clinical research and treatment options

Summarize scientific findings from medical journals

Characterisation of Neuropsychological and Motoric Performance in Patients With Hyponatremia

Not Applicable

Completed

Conditions: Hyponatremia

Interventions: Other: Neuropsychological and motoric tests

First Posted Date: 2013-06-18

Last Posted Date: 2022-05-25

Lead Sponsor: University of Cologne

Target Recruit Count: 189

Registration Number: NCT01879774

Locations: 🇪🇸
Hospital Universitario Clinico San Carlos, Madrid, Spain
🇮🇹
Dipartimento di Scienze Biomediche, Sperimentali e Cliniche Mario Serio, Firenze, Italy
🇩🇪
University of Cologne, Cologne, Germany

Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study

Phase 3

Completed

Conditions: Psoriatic Arthritis

Interventions: Drug: Placebo
Drug: Tofacitinib 10 mg BID
Drug: Tofacitinib 5 mg BID
Drug: Adalimumab

First Posted Date: 2013-06-14

Last Posted Date: 2017-07-06

Lead Sponsor: Pfizer

Target Recruit Count: 422

Registration Number: NCT01877668

Locations: 🇫🇷
Centre Hospitalier Sud-Francilien - Secretariat de Rhumatologie, Corbeil Essonnes cedex, France
🇺🇸
Arthritis Center, Inc., Palm Harbor, Florida, United States
🇨🇿
Revmatologie s.r.o., Brno, Czechia

and more 120 locations

Efficacy of Hybrid Systems in Comparison to the Rigid Spondylodesis in Lumbar-spine Fusion

Not Applicable

Terminated

Conditions: Spondylolisthesis

First Posted Date: 2013-05-13

Last Posted Date: 2015-09-16

Lead Sponsor: University of Cologne

Target Recruit Count: 5

Registration Number: NCT01852526

Locations: 🇩🇪
University hospital, Department of orthopedics & traumasurgery, Cologne, NRW, Germany
🇩🇪
University hospital, Department of orthopedics, Halle, Sachsen-Anhalt, Germany

Non-invasive Measuring of Cerebral Perfusion After Severe Brain Injury With Near-infrared-spectroscopy and ICG

Not Applicable

Conditions: Subarachnoid Hemorrhage, Aneurysmal
Intracerebral Hemorrhage (ICH)
Traumatic Brain Injury

Interventions: Procedure: measuring cerebral perfusion by NIRS with ICG

First Posted Date: 2013-04-22

Last Posted Date: 2013-04-22

Lead Sponsor: University of Cologne

Target Recruit Count: 30

Registration Number: NCT01836848

Locations: 🇩🇪
Departement of General Neurosurgery of th University of Cologne, Cologne, Germany

Cerament Treatment of Fracture Defects

Not Applicable

Completed

Conditions: AO 41-B2 and AO 41-B3 Tibia Fractures

Interventions: Procedure: Autologous cancellous bone graft
Device: CERAMENT™|BONE VOID FILLER

First Posted Date: 2013-04-11

Last Posted Date: 2019-03-04

Lead Sponsor: Johannes Gutenberg University Mainz

Target Recruit Count: 137

Registration Number: NCT01828905

Locations: 🇩🇪
Clinics of Musculoskeletal Surgery and Laboratory for Biomechanics, University of Schleswig-Holstein, Campus of Lübeck, Lübeck, Schleswig-Holstein, Germany
🇩🇪
Centre for Trauma surgery, Orthopaedics and Hand Surgery, Clinics of Worms, Worms, Rhineland-Palatinate, Germany
🇩🇪
Clinic of Orthopaedics and Trauma Surgery, Hochtaunus-Kliniken gGmbH, Bad Homburg, Hesse, Germany

and more 13 locations

Quantification of Drugs and Their Degradation Products

Not Applicable

Conditions: Liver Insufficiency
Kidney Failure, Chronic
Obesity
Pregnancy
Breast Feeding, Exclusive
Sepsis
Multiple Organ Failure

Interventions: Other: additional blood withdrawals

First Posted Date: 2013-04-10

Last Posted Date: 2013-04-10

Lead Sponsor: University of Cologne

Target Recruit Count: 1000

Registration Number: NCT01828372

Locations: 🇩🇪
Department of Pharmacology, Cologne University Hospital, Cologne, NRW, Germany

The Vascutek Custom Fenestrated Anaconda Post-Market Surveillance Study

Terminated

Conditions: Abdominal Aortic Aneurysms (AAA)

First Posted Date: 2013-04-08

Last Posted Date: 2015-12-09

Lead Sponsor: Vascutek Ltd.

Target Recruit Count: 628

Registration Number: NCT01826344

Locations: 🇳🇱
Maastricht University Medical Centre, Maastricht, Netherlands
🇦🇹
Krankenhaus Hietzing, Vienna, Austria
🇧🇪
Grand Hôpital de Charleroi, Charleroi, Belgium

and more 67 locations

Cologne Cohort of Neutropenic Patients (CoCoNut)

Recruiting

Conditions: Hematological Malignancies
Cancer
Chemotherapy
Immunosuppression
Neutropenia

Interventions: Drug: Antiinfectives

First Posted Date: 2013-04-01

Last Posted Date: 2013-04-01

Lead Sponsor: University Hospital of Cologne

Target Recruit Count: 100000

Registration Number: NCT01821456

Locations: 🇩🇪
University Hospital of Cologne, Cologne, North Rhine-Westphalia, Germany

Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants

Phase 3

Completed

Conditions: HIV
HIV Infections

Interventions: Drug: E/C/F/TDF
Drug: E/C/F/TAF
Drug: EFV/FTC/TDF
Drug: RTV
Drug: ATV
Drug: FTC/TDF
Drug: COBI

First Posted Date: 2013-03-21

Last Posted Date: 2021-04-13

Lead Sponsor: Gilead Sciences

Target Recruit Count: 1443

Registration Number: NCT01815736

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Southwest Infectious Disease Clinical Research, Inc., Dallas, Texas, United States
🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

and more 164 locations

Translational Therapy in Patients With Osteogenesis Imperfecta - A Pilot Trial on Treatment With the Rankl-Antibody Denosumab

Phase 2

Completed

Conditions: Osteogenesis Imperfecta

Interventions: Drug: Denosumab

First Posted Date: 2013-02-27

Last Posted Date: 2015-01-27

Lead Sponsor: University of Cologne

Target Recruit Count: 10

Registration Number: NCT01799798

Locations: 🇩🇪
University Cologne, Childrens Hospital, Cologne, Germany, Cologne, NRW, Germany